These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 15566392)

  • 1. Randomized trial of a single, double and triple dose of 10 mg/kg of a human formulation of triclabendazole in patients with fascioliasis.
    Talaie H; Emami H; Yadegarinia D; Nava-Ocampo AA; Massoud J; Azmoudeh M; Mas-Coma S
    Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):777-82. PubMed ID: 15566392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triclabendazole in the treatment of human fascioliasis: a community-based study.
    el-Morshedy H; Farghaly A; Sharaf S; Abou-Basha L; Barakat R
    East Mediterr Health J; 1999 Sep; 5(5):888-94. PubMed ID: 10983527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effect of triclabendazole in patients with fascioliasis in Egypt. A preliminary study.
    Hammouda NA; el-Mansoury ST; el-Azzouni MZ; el-Gohari Y
    J Egypt Soc Parasitol; 1995 Apr; 25(1):137-43. PubMed ID: 7602156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of human chronic fascioliasis with triclabendazole: drug efficacy and serologic response.
    Apt W; Aguilera X; Vega F; Miranda C; Zulantay I; Perez C; Gabor M; Apt P
    Am J Trop Med Hyg; 1995 Jun; 52(6):532-5. PubMed ID: 7611560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled pilot study of artesunate versus triclabendazole for human fascioliasis in central Vietnam.
    Hien TT; Truong NT; Minh NH; Dat HD; Dung NT; Hue NT; Dung TK; Tuan PQ; Campbell JI; Farrar JJ; Day JN
    Am J Trop Med Hyg; 2008 Mar; 78(3):388-92. PubMed ID: 18337331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of two single-day regimens of triclabendazole for fascioliasis in Peruvian children.
    Maco V; Marcos L; Delgado J; Herrera J; Nestares J; Terashima A; Samalvides F; Gotuzzo E
    Rev Soc Bras Med Trop; 2015; 48(4):445-53. PubMed ID: 26312936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imported Fasciola hepatica infection in the United States and treatment with triclabendazole.
    Graham CS; Brodie SB; Weller PF
    Clin Infect Dis; 2001 Jul; 33(1):1-5. PubMed ID: 11389487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of metronidazole in treating human fascioliasis.
    Mansour-Ghanaei F; Shafaghi A; Fallah M
    Med Sci Monit; 2003 Oct; 9(10):PI127-30. PubMed ID: 14523339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of two doses of triclabendazole in treatment of patients with combined schistosomiasis and fascioliasis.
    Osman MM; Shehab AY; Zaki A; Farag HF
    East Mediterr Health J; 2011 Apr; 17(4):266-70. PubMed ID: 22259882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A praziquantel-ineffective fascioliasis case successfully treated with triclabendazole.
    Ishii Y; Nakamura-Uchiyama F; Nawa Y
    Parasitol Int; 2002 Jun; 51(2):205-9. PubMed ID: 12113760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eight cases of fascioliasis: clinical and microbiological features.
    Dauchy FA; Vincendeau P; Lifermann F
    Med Mal Infect; 2006 Jan; 36(1):42-6. PubMed ID: 16309872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human fascioliasis in Egyptian children: successful treatment with triclabendazole.
    el-Karaksy H; Hassanein B; Okasha S; Behairy B; Gadallah I
    J Trop Pediatr; 1999 Jun; 45(3):135-8. PubMed ID: 10401189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgM and IgG cystatin capture enzyme linked immunosorbent assays: a tool for serodiagnosis and assessment of cure of acute fascioliasis after triclabendazole (TCZ; Fasinex) therapy.
    Tawfeek GM; Hussein DA
    J Egypt Soc Parasitol; 2000 Dec; 30(3):679-97. PubMed ID: 11198366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic fascioliasis: case report and review.
    Abdul-Hadi S; Contreras R; Tombazzi C; Alvarez M; Melendez M
    Rev Inst Med Trop Sao Paulo; 1996; 38(1):69-73. PubMed ID: 8762643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment Failure after Multiple Courses of Triclabendazole among Patients with Fascioliasis in Cusco, Peru: A Case Series.
    Cabada MM; Lopez M; Cruz M; Delgado JR; Hill V; White AC
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004361. PubMed ID: 26808543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human fascioliasis successfully treated with triclabendazole.
    Laird PP; Boray JC
    Aust N Z J Med; 1992 Feb; 22(1):45-7. PubMed ID: 1580862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The treatment of human fascioliasis with triclabendazole].
    Caminal Montero L; Fernández Fernández C; de Quirós JF; Parra F
    Rev Clin Esp; 1999 May; 199(5):333-5. PubMed ID: 10396163
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of food on the bioavailability of triclabendazole in patients with fascioliasis.
    Lecaillon JB; Godbillon J; Campestrini J; Naquira C; Miranda L; Pacheco R; Mull R; Poltera AA
    Br J Clin Pharmacol; 1998 Jun; 45(6):601-4. PubMed ID: 9663817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of triclabendazole is safe and effective in controlling fascioliasis in an endemic community of the Bolivian Altiplano.
    Villegas F; Angles R; Barrientos R; Barrios G; Valero MA; Hamed K; Grueninger H; Ault SK; Montresor A; Engels D; Mas-Coma S; Gabrielli AF
    PLoS Negl Trop Dis; 2012; 6(8):e1720. PubMed ID: 22880138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized comparative trial of two high-dose albendazole regimens for uncomplicated human strongyloidiasis.
    Singthong S; Intapan PM; Wongsaroji T; Maleewong W
    Southeast Asian J Trop Med Public Health; 2006; 37 Suppl 3():32-4. PubMed ID: 17547048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.